(Q53925923)

English

Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Christopher Griffiths

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

author name string

Ho VC

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Albrecht G

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Vanaclocha F

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

León-Dorantes G

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Atakan N

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Reitamo S

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Ohannesson A

8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Mørk NJ

9

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Clarke P

10

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Pfister P

11

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Paul C

12

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

141

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

283-291

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

A systematic review of five systemic treatments for severe psoriasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Cutaneous squamous-cell carcinoma in patients treated with PUVA.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Methotrexate in psoriasis: consensus conference

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Relapse rates in moderately severe chronic psoriasis treated with cyclosporin A.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Long-term safety of cyclosporine in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.02977.X

21 January 2018

Identifiers

10.1046/J.1365-2133.1999.02977.X

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10468801

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53925923&oldid=975278755"